KASEY LEE: Open Payments
NPI 1295345940 · GLASGOW, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 18 payments from 11 companies in 2025. Trend: 2023 $230 · 2024 $273 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| ABBVIE INC. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| IBSA Pharma Inc. | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Verona Pharma, Inc. | 1 | $15 |
Products named: AIRSUPRA, BREZTRI, QULIPTA, TRINTELLIX, FANAPT, JOURNAVX, Tirosint, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
